Envision Scientific
Envision Scientific is a global leader in drug delivery technology, specializing in the research, development, and manufacturing of Drug-Eluting Stents (DES) and Drug-Coated Balloons (DCB). With a focus on innovation, quality, and safety, the company produces over one million drug delivery devices annually, impacting millions of patients worldwide. As part of the Concept Medical Group, Envision Scientific is committed to advancing healthcare solutions through proprietary processes, state-of-the-art research, and rigorous quality control.
Industries
Nr. of Employees
small (1-50)
Envision Scientific
Office 801–802, Trinity Orion, Beside Jolly Residency, Vesu, Surat-395 007, Gujarat, India.
Patents
Re-establishment of blood flow in blocked human arteries by transferring nano-encapsulated drug through medical devices, designed for the same and releasing the nano-encapsulated drug in human artery with body ph
US-9259518-B2
View DetailsRe-establishment of blood flow in blocked human arteries by transferring nano-encapsulated drug through medical devices, designed for the same and releasing the nano-encapsulated drug in human artery with body ph
US-8778013-B2
View DetailsCatheter system for protected angioplasty and stenting at a carotid bifurcation
US-7645296-B2
View Details
Re-establishment of blood flow in blocked human arteries by transferring nano-encapsulated drug through medical devices, designed for the same and releasing the nano-encapsulated drug in human artery with body ph
US-9259518-B2
View DetailsRe-establishment of blood flow in blocked human arteries by transferring nano-encapsulated drug through medical devices, designed for the same and releasing the nano-encapsulated drug in human artery with body ph
US-8778013-B2
View DetailsCatheter system for protected angioplasty and stenting at a carotid bifurcation
US-7645296-B2
View DetailsProducts
Drug-eluting stents (DES)
Vascular stent platforms engineered for localized, controlled release of therapeutic agents using advanced coating methods (including polymer-free and biodegradable coatings) to reduce restenosis and support vessel healing.
Drug-coated balloons (DCB)
Balloon catheter platforms with nano-coatings to deliver antiproliferative drugs (e.g., sirolimus-class compounds) to vascular tissue during angioplasty procedures for coronary, peripheral and other vascular indications.
Drug-eluting stents (DES)
Vascular stent platforms engineered for localized, controlled release of therapeutic agents using advanced coating methods (including polymer-free and biodegradable coatings) to reduce restenosis and support vessel healing.
Drug-coated balloons (DCB)
Balloon catheter platforms with nano-coatings to deliver antiproliferative drugs (e.g., sirolimus-class compounds) to vascular tissue during angioplasty procedures for coronary, peripheral and other vascular indications.
Services
Manufacture and supply of drug-eluting stents and drug-coated balloons at scale for global partners and distributors.
Laboratory services including chromatographic analysis, microbiology, particulate testing and accelerated/real-time stability studies to support product release and shelf-life validation.
Manufacture and supply of drug-eluting stents and drug-coated balloons at scale for global partners and distributors.
Laboratory services including chromatographic analysis, microbiology, particulate testing and accelerated/real-time stability studies to support product release and shelf-life validation.
Expertise Areas
- Medical device manufacturing for vascular drug-delivery devices
- Drug delivery system development (stents and balloon catheters)
- Nanotechnology-based coating and carrier design
- Analytical testing and stability studies for medical devices
Key Technologies
- Drug-eluting stent manufacturing
- Drug-coated balloon manufacturing
- Polymer-free nanocarrier drug delivery
- Nanocoating technologies for vascular devices
News & Updates
Concept Medical announces the first patient enrollment in the MAGICAL BTK IDE Trial, marking a milestone in peripheral artery disease treatment options in the US.
The SirPAD trial, evaluating the treatment of Peripheral Artery Disease using MagicTouch PTA Sirolimus Coated Balloon, completes patient enrollment.
The trial aims to evaluate the efficacy of MagicTouch PTA Sirolimus Coated Balloon in treating below-the-knee arterial disease.
This trial is the largest study evaluating the treatment of Peripheral Artery Disease with MagicTouch PTA Sirolimus Coated Balloon.
Concept Medical announces the first patient enrollment in the MAGICAL BTK IDE Trial, marking a milestone in peripheral artery disease treatment options in the US.
The SirPAD trial, evaluating the treatment of Peripheral Artery Disease using MagicTouch PTA Sirolimus Coated Balloon, completes patient enrollment.
The trial aims to evaluate the efficacy of MagicTouch PTA Sirolimus Coated Balloon in treating below-the-knee arterial disease.
This trial is the largest study evaluating the treatment of Peripheral Artery Disease with MagicTouch PTA Sirolimus Coated Balloon.